Method of predicting genetic risk for hypertension

Details Method of predicting genetic risk for hypertension Method of predicting genetic risk for hypertension

2003-09-22

2009-08-11

Johannsen, Diana B (Department: 1634)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C536S023500

Reexamination Certificate

active

07572576

ABSTRACT:
It is intended to provide a means of predicting genetic risk for hypertension at a high accuracy and high prediction possibility. Namely, risk for hypertension is predicted by a method involving the following steps: (i) the step of analyzing two or more polymorphisms selected from among 4 gene polymorphisms having been revealed as relating to hypertension; (ii) the step of determining the genotype of a nucleic acid sample based on the polymorphism data obtained in the above step; and (iii) the step of predicting the genetic risk for hypertension from the genotype thus determined.

REFERENCES:
patent: 5474796 (1995-12-01), Brennan
patent: 5827730 (1998-10-01), Pedersen et al.
patent: 2002/0086297 (2002-07-01), Siffert
patent: 2006/0099590 (2006-05-01), Yamada et al.
patent: 0 955 382 (1999-11-01), None
patent: 0 955 382 (1999-11-01), None
patent: 2004-065203 (2004-03-01), None
patent: 94/29345 (1994-12-01), None
patent: 97/43442 (1997-11-01), None
patent: 00/15785 (2000-03-01), None
patent: 01/62796 (2001-08-01), None
patent: 01/75065 (2001-10-01), None
Izawa, H. et al. Hypertension 41:1035-1040 (Mar. 2003).
Mettimano, M. et al. British Journal of Biomedical Science 60(1):19-21 (Apr. 2003).
Gonzalez, P. et al. Genes and Immunity 2:191-195 (Jun. 2001).
Groenendijk, M. et al. Journal of Lipid Research 42:188-194 (Feb. 2001).
Peacock, R.E. et al. Genetic Epidemiology 14:265-282 (1997).
Y. Yamada, et al.; “Prediction of the Risk of Myocardial Infarction from Polymorphisms in Candidate Genes;”The New England Journal of Medicine; vol. 347; No. 24; Dec. 12, 2002; pp. 1916-1923 and Supplementary Appendix (5 Sheets.)/Discussed in the specification.
Lifton R.P. et al. Molecular mechanisms of human hypertension. Cell. 2001; 104:545-556.
Xu X., et al. An extreme-sib-pair genome scan for genes regulating blood pressure. Am J Hum Genet. 1999;64:1694-1701.
Krushkal J. et al. Genome-wide linkage analysis of systolic blood pressure using highly discordant sibblings. Circulation. 1999;99:1407-1410.
Rice T. et al. Genome-wide linkage analysis of systolic and diastolic blood pressure: the Quebec Family Study. Circulation. 2000;102:1956-1963.
Jeunemaitre X. et al. Molecular basis of human hypertension: Role of Angiotensinogen. Cell. 1992;71:169-180.
Cusi D. et al. Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension. Lancet. 1997;349:1353-1357.
Siffert W. et al. Association of a human G-protein β3 subunit variant with hypertension. Nat Genet. 1998;18:45-48.
Bray M.S. et al. Positional genomic analysis identifies the β2-Adrenergic receptor gene as a susceptibility locus for hypertension. Circulation. 2000; 101:2877-2882.
Pausova Z. et al. Role of tumor necrosis factor-α gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension. 2000;36: 14-19.
Frossard P.M. et al, A study of five human cytokine genes in human essential hypertension. Mol. Immunol. 2002; 38:969-976.
Zinman B. et al. Circulating tumor necrosis factor-α concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin. Endocrinol. Metab. 1999;84:272-278.
Kahaleh M.B. et al. Effect of cytokines on the production of endothelin by endothelial cells. Clin. Exp. Rheumatol. 1997;15:163-167.
Winkler G. et al. Elevated serum TNF-α level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients. Diabetic Med. 1999;16:207-211.
Bush E. et al. CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension. Hypertension. 2000;36:360-363.
Abe H. et al. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J. Clin. Invest. 1998;101:1784-1788.
Andrioli G. et al, Study of platelet adhesion in patients with uncomplicated hypertension. J. Hypertension. 1996;14:1215-1221.
Dockrell M. E. et al. Platelet aggregation in young men contrasting predisposition to high blood pressure. Am. J. Hypertension. 1999;12:115-119.
Bereczki, Cs. et al. The roles of platelet function, thromboxane, blood lipids, and nitric oxide in hypertension of children and adolescents. Prostaglandins Leukot. Essent. Fatty Acids. 2000;62:293-297.
Murata M. et al. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation. 1997;96:3281-6.
Kroll, H. et al. The impact of the glycoprotein la collagen receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction. Thromb Haemost. 2000;83:392-396.
Nicolas von Beckerath et al. “G Protein β3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement” Atherosclerosis, 2000, 149, 151-155.
Juliano C. Padovani et al. “Gene Polymorphisms in the TNF Locus and the Risk of Myocardial Infarction” Thrombosis Research, 2000, 100, 263-269.
Douglas H. et al. “Platelet member glycoprotein Ibα gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis” Heart, 2002, 87, 70-74.
M. K. Halushka et al., “Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis,”Nature Genetics,vol. 22, Jul. 1999, pp. 239-247.
A. Bonnardeaux et al., “Angiotensin II Type 1 Receptor Gene Polymorphisms in Human Essential Hypertension,”Hypertension,vol. 24, No. 1, Jul. 1994, pp. 63-69.
X. Jeunemaitre et al., “Molecular Basis of Human Hypertension: Role of Angiotensinogen,”Cell,vol. 71, Oct. 1992, pp. 169-180.
F. Navarro-López, “Bases genéticas de la enfermedad coronaria,”Revista Espanola de Cardiologia,vol. 55, No. 4, Apr. 2002, pp. 413-431. English abstract only.
Sinan Tas, “Blood pressure, coronary artery disease, and glycaemic control in type 2 diabetes mellitus: relation to apollpoprotein-CIII gene polymorphism,” The Lancet, vol. 343, May 14, 1994, pp. 1194-1195.

Affiliated with

Also associated with

Rating

Method of predicting genetic risk for hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of predicting genetic risk for hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of predicting genetic risk for hypertension will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4058551